Skip to content
Menu

Kyverna Therapeutics, Inc. KYTX

Full chart Compare
Set alert

Price alert · KYTX

All alert types
4.37 USD -0.11 (-2.46%)

Regular-session close

4.89 +0.52 +12.00%

After hours · Nov 19, 4:00 PM ET

4.30 Day range 4.62
4.30 52-week range 13.67
YTD
-53.51%
1 year
-46.90%

Revenue & Expenses

Revenue Profit Costs
Other Income$491.00KGross Profit$7.03MNet Loss$28.89MExpenses$36.41MSelling, General & Admin$8.01MResearch & Development$28.40MRevenue$7.03M

Latest period ending Dec 31, 2025 · select a line to chart its full history

Annual income statement

KYTX annual income statement
Fiscal yearFY 2025 Dec 31, 2025FY 2024 Dec 31, 2024FY 2023 Dec 31, 2023FY 2022 Dec 31, 2022FY 2021 Dec 31, 2021
169.83M142.60M62.41M36.41M32.00M
133.72M112.47M49.92M28.40M25.85M
36.11M30.13M12.48M8.01M6.15M
-169.83M-142.60M-62.41M-29.38M-26.35M
489.00K142.00K187.00K65.00K3.00K
-161.31M-127.48M-60.37M-28.89M-26.35M
-161.31M-127.48M-60.37M-28.89M-26.35M
-161.31M-127.48M-60.37M-28.89M-26.35M
-161.31M-127.48M-60.37M-28.89M-26.35M
-3.64-3.33-89.61-63.43-99.10
-3.64-3.33-89.61-63.43-99.10
-3.64-3.33-89.61-63.43-99.10
-160.82M-127.33M-60.18M-28.83M-26.35M
-160.82M-127.33M-60.18M-28.83M-26.35M
44.26M38.33M673.62K455.48K265.88K
44.26M38.33M673.62K455.48K265.88K